腹腔镜胃切除术治疗进展期胃癌15年经验:短期与长期肿瘤学结局分析
该回顾性研究纳入2003年5月至2017年5月首尔大学盆唐医院因进展期胃癌行腹腔镜胃切除术的1483例患者(排除109例中转开腹),分析短期和长期肿瘤学结局。总并发症率9.1%,Clavien-Dindo分级3级及以上并发症率4.9%,多因素分析仅年龄为显著危险因素。5年总生存率按分期从IB期88.9%至IV期25%,总复发率14.4%。结论认为由经验丰富的外科医生实施时,腹腔镜胃切除术在进展期胃癌的常规实践中安全可行。
要点
- 进展期胃癌腹腔镜胃切除术总并发症率9.1%,严重并发症(Clavien-Dindo≥3级)率4.9%。
- 多因素分析仅年龄是并发症的显著危险因素(OR 1.02;95%CI 1.01-1.04,P=0.01)。
- 5年总生存率分期IB 88.9%、IIA 88.7%、IIB 84.2%、IIIA 71.7%、IIIB 56.8%、IIIC 45.4%、IV 25%。
核心结论
- 在15年经验中成功完成1483例进展期胃癌腹腔镜胃切除术,短期和长期肿瘤学结局与其他研究相当。
- 由经验丰富的外科医生实施时,腹腔镜胃切除术在进展期胃癌的常规实践中安全可行。
研究设计与样本
- 回顾性综述,纳入2003年5月至2017年5月首尔大学盆唐医院因进展期胃癌行腹腔镜胃切除术的1592例患者,排除109例中转开腹,最终分析1483例。
主要发现
- 手术方式包括全胃切除术432例、远端胃切除术982例、近端胃切除术69例。
- 总并发症率9.1%(135/1483),包括伤口相关并发症0.7%、术后出血0.5%、吻合口或残端漏2.2%、肠梗阻0.9%、胰瘘0.1%、腹腔脓肿1.6%、肺部并发症3.0%。
- Clavien-Dindo分级3级及以上并发症率为4.9%。
- 多因素分析中年龄是唯一显著危险因素(OR 1.02;95% CI,1.01-1.04,P = 0.01)。
- 5年总生存率按分期:IB期88.9%、IIA期88.7%、IIB期84.2%、IIIA期71.7%、IIIB期56.8%、IIIC期45.4%、IV期25%;总复发率14.4%,包括局部复发1.1%和远处转移13.3%。
临床怎么用
- 对于进展期胃癌,经验丰富的外科医生可考虑行腹腔镜胃切除术,其短期和长期肿瘤学结局与既往研究相当。
局限性
- 本研究为单中心回顾性研究,证据等级有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Laparoscopic gastrectomy (LG) is now a widely accepted treatment option for gastric cancer. However, there is insufficient evidence for LG for advanced gastric cancer (AGC). Many retrospective studies have shown that LG for AGC is safe and feasible, but very few studies have shown the actual outcome in general practice. The aim of this study is to analyze our last 15 years of experience in LG for AGC. METHODS: This is a retrospective review from May 2003 to May 2017 in Seoul National University Bundang Hospital. A total of 1592 patients who had LG for AGC were enrolled of which 109 patients with open conversion were excluded. We evaluated the short-term and long-term oncologic outcomes of LG for AGC. RESULTS: A total of 1483 patients were analyzed. There were 432 cases of total gastrectomy, 982 cases of distal gastrectomy, and 69 cases of proximal gastrectomy. The total complication rate was 9.1% (135/1483), which included wound-related complications (0.7%), postoperative bleeding (0.5%), anastomosis or stump leakage (2.2%), intestinal obstruction (0.9%), pancreatic fistula (0.1%), intra-abdominal abscess (1.6%), and lung morbidity (3.0%). The rate of Clavien-Dindo grade 3 and above complications was 4.9%. Age was the only significant risk factor in multivariate analysis (OR 1.02; 95% CI, 1.01-1.04, P = 0.01). 5-year overall survival stratified by stage was as follows: stage IB 88.9%, stage IIA 88.7%, stage IIB 84.2%, stage IIIA 71.7%, stage IIIB 56.8%, stage IIIC 45.4%, and stage IV 25%. Total recurrence rate was 14.4%, which included local recurrence (1.1%) and distant metastases (13.3%). CONCLUSIONS: During our 15 years of experience, we have successfully performed 1483 cases of AGC with laparoscopy. Our results showed short-term and long-term oncologic outcomes that were comparable with other studies. LG is safe and feasible in general practice for advanced gastric cancer when performed by experienced surgeons.
引用
- Min SH, Won Y, Kim G, et al. 15-year experience of laparoscopic gastrectomy in advanced gastric cancer: analysis on short-term and long-term oncologic outcome. Surg Endosc. 2019. PMID: 31820153. doi:10.1007/s00464-019-07292-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。